Clinical Laserthermia Systems AB (publ) (STO:CLS.B)

STO:CLS.B Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	13.2	22.51	15.33	10.45	1.71	0.6
Short-Term Investments	-	-	-	0.14	29.46	11.28
Cash & Short-Term Investments	13.2	22.51	15.33	10.59	31.17	11.87
Cash Growth	-15.29%	46.80%	44.80%	-66.03%	162.53%	106.06%
Accounts Receivable	3.19	4.59	2.64	1.5	0.64	0.46
Other Receivables	1.89	2.18	2.14	8.89	5.81	2.9
Receivables	5.09	6.77	4.78	10.4	6.45	3.36
Inventory	7.96	8.15	6.12	3.07	4.61	5.61
Prepaid Expenses	0.35	0.98	0.92	0.2	0.2	0.06
Total Current Assets	26.59	38.41	27.15	24.26	42.43	20.9
Property, Plant & Equipment	3.52	13.14	3.88	1.8	1.48	2.05
Other Intangible Assets	4.91	2.56	5.83	2.48	2.28	2.24
Long-Term Accounts Receivable	-	-	-	0.12	0.08	0.2
Long-Term Deferred Tax Assets	12.31	13.53	7.82	5.66	3.04	-
Long-Term Deferred Charges	6.98	10.93	13.06	15.18	17.31	19.01
Other Long-Term Assets	9.82	-	-	-	0.12	-
Total Assets	64.13	78.56	57.73	49.51	66.74	44.4
Accounts Payable	2.83	6.3	9.17	5.93	4.31	4.46
Accrued Expenses	2.84	4.84	3.18	3.43	1.75	4.14
Short-Term Debt	-	-	-	30.68	35	-
Current Portion of Long-Term Debt	-	-	-	-	0.17	0.47
Current Portion of Leases	0.22	0.22	0.23	-	-	-
Current Income Taxes Payable	0.09	0.07	0.18	0.45	0.31	-
Other Current Liabilities	1.33	1.45	1.22	1.16	3.92	20.96
Total Current Liabilities	7.3	12.87	13.97	41.64	45.45	30.03
Long-Term Debt	-	-	-	-	0.1	0.2
Long-Term Leases	0.01	0.01	0.22	-	-	-
Other Long-Term Liabilities	-	-0	-	-	-	0.24
Total Liabilities	7.31	12.87	14.2	41.64	45.55	30.47
Common Stock	58.52	46.58	15.43	12.05	6.09	4.21
Additional Paid-In Capital	3.08	39.95	9.8	66.13	339.83	270.44
Retained Earnings	-1.25	-17.77	19.63	-67.7	-323.83	-263.07
Comprehensive Income & Other	-0.79	-0.03	0.92	-1.26	-0.3	2.36
Total Common Equity	59.56	68.72	45.77	9.22	21.79	13.93
Minority Interest	-2.74	-3.04	-2.24	-1.35	-0.61	-
Shareholders' Equity	56.82	65.69	43.53	7.87	21.18	13.93
Total Liabilities & Equity	64.13	78.56	57.73	49.51	66.74	44.4
Total Debt	0.22	0.22	0.45	30.68	35.27	0.67
Net Cash (Debt)	12.97	22.28	14.88	-20.09	-4.11	11.2
Net Cash Growth	-14.23%	49.78%	-	-	-	138.88%
Net Cash Per Share	0.59	2.02	4.43	-48.17	-14.29	50.71
Filing Date Shares Outstanding	31.17	20.17	6.68	0.65	0.33	0.23
Total Common Shares Outstanding	25.67	20.17	6.68	0.65	0.33	0.23
Working Capital	19.29	25.54	13.17	-17.38	-3.03	-9.13
Book Value Per Share	2.32	3.41	6.85	14.15	66.22	61.28
Tangible Book Value	54.65	66.16	39.94	6.74	19.52	11.69
Tangible Book Value Per Share	2.13	3.28	5.98	10.34	59.30	51.44
Machinery	-	6.67	5.04	4.25	4.21	4.06
Construction In Progress	-	8.36	-	-	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.